Skip to main content
. 2023 Jul 18;12(14):14881–14891. doi: 10.1002/cam4.5843

FIGURE 3.

FIGURE 3

Survival curves of subgroups between patients who chose immunotherapy and no‐immunotherapy as the second‐line treatment in the chemotherapy group.